--- title: "Viking Holdings Ltd Stock 12‑Month Price Target Raised to $92, Implies 6% Upside" type: "News" locale: "en" url: "https://longbridge.com/en/news/286523824.md" description: "Viking Holdings Ltd's average stock price target has been raised from $91.33 to $92, indicating a potential upside of 6%. The consensus rating remains 'Buy' among 19 analysts, with 14 Buys, 4 Holds, and 1 Sell. Price forecasts range from $75 to $112 per share." datetime: "2026-05-15T07:20:12.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/286523824.md) - [en](https://longbridge.com/en/news/286523824.md) - [zh-HK](https://longbridge.com/zh-HK/news/286523824.md) --- # Viking Holdings Ltd Stock 12‑Month Price Target Raised to $92, Implies 6% Upside - According to estimates from 18 analysts, Viking Holdings Ltd stock's average price target has risen from $91.33 to $92, with forecasts ranging from $75 to $112 per share - Based on the May 14 closing price, the updated target implies approximately 6% potential upside - Consensus rating remains at “Buy” across 19 covering analysts, with 14 Buys, 4 Holds and 1 Sells Explore more price target data and ratings for Viking Holdings Ltd on the , and track all previous and future analyst recommendations for Viking Holdings Ltd in the dedicated News Flow. **Disclaimer** Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice. ### Related Stocks - [VIK.US](https://longbridge.com/en/quote/VIK.US.md) ## Related News & Research - [Viking Holdings Analysts Boost Their Forecasts Following Better-Than-Expected Q1 Results](https://longbridge.com/en/news/286577548.md) - [What To Expect From Viking’s (VIK) Q1 Earnings](https://longbridge.com/en/news/286188619.md) - [Viking Stock Jumps As Cruise Demand Stays Strong, Company Names New CEO](https://longbridge.com/en/news/286461894.md) - [Best Buy leak hints GTA VI pre-orders may start May 18](https://longbridge.com/en/news/286472709.md) - [Assessing BioMarin Pharmaceutical (BMRN) Valuation After Prolonged Share Price Weakness](https://longbridge.com/en/news/286895616.md)